BioCryst Pharmaceuticals Inc BCRX Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Pharmaceuticals Inc (BCRX) Financials

BioCryst Pharmaceuticals Inc (BCRX)

7.31

-0.18

(-2.40%)

At close: 19 December 8:00AM

Delayed by 15 minutes

7.2999

-0.0101

( -0.14% )

After Hours: 11:07AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-51.44	-49.072	-62.29	-67.612	-71.692	-39.889	-43.424	-42.464
Return on Equity (%)	-223.699	-154.155	-152.256	-248.944	-1925.371	291.588	123.071	60.4
Return on Invested Capital (%)	-899.796	-155.025	-165.44	-149	-194.159	-294.372	570.588	89.419
Operating Margin (%)	-184.636	-227.178	-445.824	-198.638	-944.942	-77.951	-53.647	-35.602
Net Profit Margin (%)	-209.251	-261.185	-490.253	-222.99	-1026.353	-117.11	-91.245	-68.356
Book Value Per Share	0.021	0.851	0.447	0.248	-0.109	-0.58	-1.568	-2.224
Earnings Per Share	-0.747	-0.668	-0.92	-0.707	-1.034	-0.998	-1.315	-1.106
Cash Per Share	0.3	0.511	0.243	0.741	1.538	2.736	1.622	0.54
Working Capital Per Share	0.171	0.514	0.408	0.467	1.233	2.508	2.187	1.689
Operating Profit Per Share	0.333	0.251	0.188	0.293	0.092	0.818	1.415	1.604
EBIT Per Share	-0.747	-0.668	-0.92	-0.707	-1.034	-0.986	-1.301	-1.105
EBITDA Per Share	-0.747	-0.668	-0.92	-0.707	-1.034	-0.986	-1.301	-1.105
Free Cash Flow Per Share	-0.682	-0.672	-0.924	-0.709	-1.035	-0.99	-1.316	-1.104

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	73.78M	98.41M	110.06M	154.08M	176.88M	184.35M	187.91M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	187.91M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-36.736	N/A	N/A	N/A	-11.328	N/A	N/A
Net Profit Margin (%)	N/A	-77.544	N/A	N/A	N/A	-38.14	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.55B
Price to Earnings Ratio	-6.69
Price to Sales Ratio	4.58
Price to Cash Ratio	13.7
Price to Book Ratio	-3.33
Dividend Yield	-

Share Statistics

Shares Outstanding	207.13M
Average Volume (1 week)	1.73M
Average Volume (1 Month)	1.8M
52 Week Change	18.50%
52 Week High	8.88
52 Week Low	4.03

More Ratios Coming Soon!

BioCryst Pharmaceuticals

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions